Business
6 reasons CSL (ASX:CSL) shares are struggling
CSL Limited (ASX: CSL) shareholders have been tearing their hair out over the past 12 months.
The stock price has plummeted 20% during a time the rest of the market has climbed onwards and upwards from the depths of the COVID-19 crash.
It’s been a rude shock for a stock that grew spectacularly for 25 years before the pandemic.
“It took the better part of the past 2.5 decades, but Australian investors eventually warmed to Australia’s largest and most successful biotech company,” FNArena editor Rudi Filapek-Vandyck said to his subscribers.
“Just when it seemed nothing could ever possibly go wrong for Australia’s number one business success story, it somehow did.”
Its life as an ASX-listed company has been so charmed…
-
Noosa News21 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News16 hours agoHelp to make recycling stick
-
Noosa News14 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Noosa News14 hours agoBrisbane house rents record first quarter without growth since 2022